Houston, TX -- (SBWIRE) -- 12/11/2012 -- BG Medicine, Inc. (NASDAQ:BGMD) is currently trading at $3.01, 126.32% higher. BG Medicine, Inc., is a United States-based company, which provides drug research and development services. The Company focused on the discovery, development, and commercialization of novel molecular diagnostics based on biomarkers to improve patient outcomes and contain healthcare costs. Its products include avandia, and enbrel, remicade and molecular diagnostics for cardiovascular diseases, such as congestive heart failure, coronary stenosis, and vulnerable plaque, cancers, and central nervous system (CNS).
How Should Investors Trade BGMD After The Recent Volatile Moves? Find Out click my link
CARDIOME PHARMA CORP (NASDAQ:CRME) is higher 33.04% to $0.333. Cardiome Pharma Corp. (Cardiome) is a research-based biopharmaceutical company. The Company is focused on the discovery, development and commercialization of new therapies. It has one product, BRINAVESS, approved for marketing in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults. The Company’s clinical programs are also focused on the treatment of atrial fibrillation, an arrhythmia (or abnormal rhythm) of the upper chambers of the heart.
Is CRME Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis click my link
Cereplast, Inc. (NASDAQ:CERP) is higher 6.86% to $0.0561. Cereplast, Inc. (Cereplast) is engaged in developing and commercializing bio-based resins through two product families: Cereplast Compostables Resins, which are compostable, renewable, ecologically sound substitutes for petroleum-based plastics, and Cereplast Sustainables resins (including the Cereplast Hybrid Resins product line), which replaces up to 90% of the petroleum-based content of traditional plastics with materials from renewable resources.
Can CERP Rebound After The Recent Slump and Investors Can Make Money? Find Out click my link
Somaxon Pharmaceuticals, Inc. (NASDAQ:SOMX) among the gainers and the stock added 72.79% to $2.54. Somaxon Pharmaceuticals, Inc. (Somaxon) is a specialty pharmaceutical company focused on the in-licensing, development and commercialization of branded products and late-stage product candidates. Somaxon operates in one segment, which is the development and commercialization of pharmaceutical products. The Company’s focus is on commercial activities relating to Silenor.
Is SOMX Ready To Move Back To New Highs This Year? Find Out click my link
Pacific Ethanol Inc (NASDAQ:PEIX) is higher 7.48% to $0.345. Pacific Ethanol, Inc. (Pacific Ethanol) is a marketer and producer of low-carbon renewable fuels in the Western United States. Pacific Ethanol markets all the ethanol produced by four ethanol production facilities located in California, Idaho and Oregon, or the Pacific Ethanol Plants, all the ethanol produced by three other ethanol producers in the Western United States and ethanol purchased from other third-party suppliers throughout the United States.
How Should Investors Trade PEIX After The Recent Volatile Moves? Find Out click my link
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Winning Media LLC
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)